Training a new breed of clinical triallist

03 February 2022

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.

Read More

Strategic partner: AstraZeneca

11 November 2019

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge University for more than two decades. What are the secrets of their success?

Read More
Medication

Method to predict drug stability could lead to more effective medicines

05 March 2018

Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has been licensed to Cambridge spin-out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body. 

Read More

Pages